Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Jan 28, 2017 | $30.5B |
| FY2017, ended Feb 3, 2018 | $25.4B |
| FY2018, ended Feb 2, 2019 | $22.4B |
| FY2019, ended Feb 1, 2020 | $20.9B |
| FY2020, ended Jan 30, 2021 | $25.9B |
| FY2021, ended Jan 29, 2022 | $31.4B |
| FY2022, ended Jan 28, 2023 | $32.3B |
| FY2023, ended Feb 3, 2024 | $33.3B |
| FY2024, ended Feb 1, 2025 | $40.7B |
| FY2025, ended Jan 31, 2026 | $38.5B |
| Trailing 12 months to Aug 15, 2026 (through Q2 FY2026) | $33.5B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Jan 28, 2017 | $115B |
| FY2017, ended Feb 3, 2018 | $123B |
| FY2018, ended Feb 2, 2019 | $122B |
| FY2019, ended Feb 1, 2020 | $122B |
| FY2020, ended Jan 30, 2021 | $132B |
| FY2021, ended Jan 29, 2022 | $138B |
| FY2022, ended Jan 28, 2023 | $148B |
| FY2023, ended Feb 3, 2024 | $150B |
| FY2024, ended Feb 1, 2025 | $147B |
| FY2025, ended Jan 31, 2026 | $148B |
| Trailing 12 months to Aug 15, 2026 (through Q2 FY2026) | $149B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Jan 28, 2017 | $1.98B | $573M |
| FY2017, ended Feb 3, 2018 | $1.91B | $604M |
| FY2018, ended Feb 2, 2019 | $3.11B | $1.20B |
| FY2019, ended Feb 1, 2020 | $1.66B | $1.54B |
| FY2020, ended Jan 30, 2021 | $2.58B | $3.95B |
| FY2021, ended Jan 29, 2022 | $1.66B | $3.58B |
| FY2022, ended Jan 28, 2023 | $2.24B | $1.42B |
| FY2023, ended Feb 3, 2024 | $2.16B | $2.88B |
| FY2024, ended Feb 1, 2025 | $2.67B | $1.78B |
| FY2025, ended Jan 31, 2026 | $1.02B | $3.46B |
| Trailing 12 months to Aug 15, 2026 (through Q2 FY2026) | $1.08B | $2.38B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Jan 28, 2017 | $322M |
| FY2017, ended Feb 3, 2018 | $347M |
| FY2018, ended Feb 2, 2019 | $429M |
| FY2019, ended Feb 1, 2020 | $399M |
| FY2020, ended Jan 30, 2021 | $1.69B |
| FY2021, ended Jan 29, 2022 | $1.82B |
| FY2022, ended Jan 28, 2023 | $1.01B |
| FY2023, ended Feb 3, 2024 | $1.88B |
| FY2024, ended Feb 1, 2025 | $3.96B |
| FY2025, ended Jan 31, 2026 | $3.33B |
| Trailing 12 months to Aug 15, 2026 (through Q2 FY2026) | $1.68B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Jan 28, 2017 | $13.3B |
| FY2017, ended Feb 3, 2018 | $14.8B |
| FY2018, ended Feb 2, 2019 | $14.4B |
| FY2019, ended Feb 1, 2020 | $13.3B |
| FY2020, ended Jan 30, 2021 | $12.4B |
| FY2021, ended Jan 29, 2022 | $11.7B |
| FY2022, ended Jan 28, 2023 | $11.3B |
| FY2023, ended Feb 3, 2024 | $10.2B |
| FY2024, ended Feb 1, 2025 | $15.9B |
| FY2025, ended Jan 31, 2026 | $15.9B |
| Trailing 12 months to Aug 15, 2026 (through Q2 FY2026) | $15.4B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 35.4% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Jan 28, 2017 | 914M |
| FY2017, ended Feb 3, 2018 | 866M |
| FY2018, ended Feb 2, 2019 | 798M |
| FY2019, ended Feb 1, 2020 | 778M |
| FY2020, ended Jan 30, 2021 | 752M |
| FY2021, ended Jan 29, 2022 | 723M |
| FY2022, ended Jan 28, 2023 | 717M |
| FY2023, ended Feb 3, 2024 | 722M |
| FY2024, ended Feb 1, 2025 | 661M |
| FY2025, ended Jan 31, 2026 | 613M |
| Trailing 12 months to Aug 15, 2026 (through Q2 FY2026) | 591M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Jan 28, 2017 | $1.77B | $141M | $68.0M |
| FY2017, ended Feb 3, 2018 | $1.63B | $151M | $51.0M |
| FY2018, ended Feb 2, 2019 | $2.01B | $154M | $65.0M |
| FY2019, ended Feb 1, 2020 | $465M | $155M | $55.0M |
| FY2020, ended Jan 30, 2021 | $1.32B | $185M | $127M |
| FY2021, ended Jan 29, 2022 | $1.65B | $203M | $172M |
| FY2022, ended Jan 28, 2023 | $993M | $190M | $134M |
| FY2023, ended Feb 3, 2024 | $62.0M | $172M | $50.0M |
| FY2024, ended Feb 1, 2025 | $4.16B | $175M | $127M |
| FY2025, ended Jan 31, 2026 | $2.70B | $157M | $182M |
| Trailing 12 months to Aug 15, 2026 (through Q2 FY2026) | $3.77B | $175M | $55.0M |
Valuation
At current price- Market Cap
- $38.9B
- P/E
- 35.9×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 0.3×
- Price / Book
- 6.7×
- EV / EBITDA
- 9.9×
Growth
Trailing 12 months- Revenue (TTM)
- $149B
- Revenue Growth YoY
- 1.6%
- Revenue CAGR 3Y
- −0.1%
- Revenue CAGR 5Y
- 2.2%
- EPS Growth YoY
- −53.0%
- Net Income Growth YoY
- −60.2%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 1.4%
- Net Margin
- 0.7%
- FCF Margin
- 1.6%
- Return on Equity
- 14.3%
Earnings
Trailing 12 months- Net Income
- $1.08B
- EPS (diluted)
- $1.85
- EBITDA
- $5.31B
- Operating Income
- $2.08B
Balance Sheet
As of Aug 15, 2026- Cash and cash equivalents
- $1.68B
- Total Debt
- $15.4B
- Net Debt
- $13.7B
- Total Assets
- $49.5B
- Total Liabilities
- $43.6B
- Shareholders' Equity
- $5.84B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $6.71B
- Capital Expenditure
- $4.32B
- Free Cash Flow
- $2.38B
Dividends and risk
Last 12 months- Dividend Yield
- 2.2%
- Dividend / Share
- $1.44
- Beta (5Y)
- 0.36
Every ratio is calculated from the company’s reported figures.